“…Homozygous and heterozygous nonsense variants affecting the DNA binding site in the homeodomain of HOXD13 lead to a variety of limb abnormalities and other skeletal defects with reduced penetrance (Jamsheer et al, 2012; Kurban et al, 2011; Low & Newbury‐Ecob, 2012). In addition, variants in the polyalanine tract domains of HOXD13 result in SPD phenotypes (Akarsu et al, 1996; Albrecht et al, 2004; Brison et al, 2012; Gong et al, 2011; Goodman et al, 1997; Kjaer et al, 2005, 2002; Tuzel et al, 2007; Zaib et al, 2019; Zhou et al, 2014). However, alterations outside of these domains can cause a wide spectrum of clinical features making the differential diagnosis complicated.…”